H/Advisors Cicero supported a global pharmaceutical company with a public affairs and policy landscaping campaign in the rare disease and orphan drug landscape. The project spanned 13 countries across Europe, North and South America, Asia-Pacific, the UK and Turkey.
Strategy and execution
H/Advisors Cicero produced a comprehensive report based on desktop research and interaction with the broader H/Advisors network in the US, Brazil, China, Japan, EU and Germany. H/Advisors Cicero also summarised our findings into a comprehensive PowerPoint deck which outlined the political and policy landscape and gave strategic advice on future engagement.
Our policy and public affairs engagement has assisted in the development of the company’s global rare disease advocacy positioning.
Working at H/Advisors Cicero
Market Research & Brand Audit
Sustainability & ESG
Thought Leadership & Integrated Campaigns
Crisis and Issues-Based Communication
Graphic Design & Content Creation
Select Committee & Media Training
Social Media Strategy & Advertising
Financial PR & Investor Relations
Video Production & Animation